Treatment as Prevention ANRS 12249, phase 1
South Africa, 2012 - 2014
Get Microdata
Reference ID
ANRS12249
Producer(s)
Dabis, François, Newell, Marie-Louise
Collections
Metadata
Created on
May 06, 2014
Last modified
Jan 19, 2015
Page views
442269
Downloads
2222
- Data files
- DBS Results
-
HIV Drug
Treatments - Households
- CBCs
- CHEs
-
Lab Test
Results -
ARTemis Lab
Results -
ARTemis
Patients -
CHE Adverse
Events - Specimens
-
Individual
Consents - SCBs SCCs
- iDART
-
CHE Action
Plans - Locations
- Clusters
- Trial Statuses
- Visits
- HHIs
- SCIs
- CFUs
- CFU Pill Tests
-
SAEs Initial
Notifications -
SAEs Initial
Notifications -
Events details -
SAEs Initial
Notifications -
Medications -
SAEs
Complementary
Notifications -
SAEs
Complementary
Notifications -
Medications - Individuals
- IQs
Reason for stopping (ReasonForStopping)
Data file: HIV Drug Treatments
Overview
Valid:
311
Invalid:
10692
Type:
Discrete
Decimal:
0
Width:
28
Range:
1 - 16
Format:
Numeric
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 1 | End of course of treatment | 0 |
0%
|
| 2 | Poor adherence | 1 |
0.3%
|
| 3 | Intolerance - Rash | 1 |
0.3%
|
| 4 | Intolerance - Hepatitis | 2 |
0.6%
|
| 5 | Lactataemia | 7 |
2.3%
|
| 6 | Lactic Acidosis | 16 |
5.1%
|
| 7 | Neuropathy | 16 |
5.1%
|
| 8 | Lipodystrophy | 104 |
33.4%
|
| 9 | Immunological failure | 0 |
0%
|
| 10 | Virological failure | 15 |
4.8%
|
| 11 | Planned interruption | 0 |
0%
|
| 12 | Other | 51 |
16.4%
|
| 13 | Unknown | 0 |
0%
|
| 14 | Entry Required | 18 |
5.8%
|
| 15 | Policy change | 62 |
19.9%
|
| 16 | TasP trial switch to Atripla | 18 |
5.8%
|
| Sysmiss | 10692 |
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Description
Universe
The patient stopped that regimen.